1 / 9

Prof. Giorgio Walter Canonica Allergy and Respiratory Diseases Department University of Genoa

Cancun , December 4, 2011. SIT Which Patients for SLIT?. Prof. Giorgio Walter Canonica Allergy and Respiratory Diseases Department University of Genoa. 1°vice President. Past President. The question is not anymore whether immunotherapy is effective and safe, but….

paniz
Download Presentation

Prof. Giorgio Walter Canonica Allergy and Respiratory Diseases Department University of Genoa

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Cancun, December 4, 2011 SIT Which Patients for SLIT? Prof. Giorgio Walter Canonica Allergy and Respiratory Diseases Department University of Genoa 1°vice President PastPresident

  2. The question is not anymore whether immunotherapy is effective and safe, but…. Who benefits from immunotherapy ? Bonini S., Rasi G. Allergy 1997;52 :693-94

  3. Canonica et al. 2009

  4. Canonica et al. 2009

  5. Canonica et al. 2009

  6. TAKE HOME MESSAGE • Evidences of single allergen SLIT effectiveness in polysensitized patients • Component Resolved Diagnosis may, more properly then in the past, indicates a better choice for SIT

  7. NO reason to talk aboutSCIT vs SLIT Are twodifferenttools in allergist’s armamentarium

More Related